Pharmacology of the carcinoid syndrome.
D006916:5-Hydroxytryptophan / Q000378:metabolism; D001920:Bradykinin / Q000494:pharmacology; D003967:Diarrhea / Q000209:etiology; D004357:Drug Synergism; D006801:Humans; D007705:Kinins / Q000494:pharmacology; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy / Q000209:etiology*; D008784:Methysergide / Q000627:therapeutic use; D009461:Neurologic Manifestations; D010649:Phenylalanine / Q000627:therapeutic use; D011453:Prostaglandins / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism / Q000494:pharmacology; D012702:Serotonin Antagonists; D012877:Skin Manifestations
D007705:Kinins; D011453:Prostaglandins; D012702:Serotonin Antagonists; D012701:Serotonin; D010649:Phenylalanine; D006916:5-Hydroxytryptophan; D001920:Bradykinin; D008784:Methysergide